Cereno Scientific presents at ABGSC Investor Days, December 5
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, is scheduled to present at the ABG Sundal Collier (ABGSC) Investor Days in Stockholm on December 5, 2024, at 08:45. CEO Sten R. Sörensen will present the Company’s pipeline and meet with potential investors.Read more about the Investor Days on the ABGSC website here . The event will be live streamed via this link